chartexchange

Taysha Gene Therapies Inc (TSHA) (Q3 2026) Earnings Call Highlights: TSHA-102 Safety Clears Key ...

GuruFocus | Nov 12, 2026 6:06 PM EST

Taysha Gene Therapies Inc (TSHA) reports no dose-limiting toxicities across 33 dosed patients, completes BLA-enabling manufacturing campaign, and eyes a potential two-quarter acceleration of its… Related Stocks: TSHA ,

Read original article